-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on GoodRx Holdings, Lowers Price Target to $5

Benzinga·11/11/2025 16:05:44
Listen to the news
JP Morgan analyst Lisa Gill maintains GoodRx Holdings (NASDAQ:GDRX) with a Overweight and lowers the price target from $6 to $5.